Skip to content

MaxLinear MXL Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

ePlus logo
ePlusPLUS
$1.85M+1.4%
BCB Bancorp logo
BCB BancorpBCBP
$250K-46.9%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$69.99M
RGC Resources logo
RGC ResourcesRGCO
$1.04M+135%
New Horizon Aircraft logo
New Horizon AircraftHOVR
$3.95M
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$1.8M-40.0%

Other financials

Income statement

See full
Revenue$168.8M+55.2%
Gross profit$97.7M+58.7%
Operating income-$4.2M+83.0%
Net income$1.8M+107%
EPS (diluted)$0.02+106%

Balance sheet

See full
Cash & equivalents$64.8M-40.3%
Total debt$148.2M+0.4%
Total equity$484.8M-0.7%
Total assets$822.6M-4.8%

Cash flow

See full
Operating cash flow-$8.9M+22.2%
CapEx$2.3M+99.5%
Free cash flow-$10.3M+23.4%

Valuation

See full
Market cap$5.35B+255%
Enterprise value$5.43B+251%
P/S9.4×+5.4×

Profitability

See full
Gross margin57.5%+1.7pp
Operating margin-13.6%-5.7pp
Net margin-18.2%-7.3pp
FCF margin2%+1.0pp

Returns & leverage

See full
Return on equity-21.3%-6.5pp
Debt / equity0.3×0.0×
Current ratio1.8×+0.2×

Where this comes from

Reported directly by MaxLinear in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: MaxLinear’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxLinear's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MaxLinear's stock issuance proceeds?
MaxLinear (MXL) reported stock issuance proceeds of $3.8M in Q2 2026.
How has MaxLinear's stock issuance proceeds changed year-over-year?
MaxLinear's stock issuance proceeds increased by 76.9% year-over-year, from $2.15M to $3.8M.
What is the long-term trend for MaxLinear's stock issuance proceeds?
Over 4 years (2021 to 2025), MaxLinear's stock issuance proceeds has grown at a -20.2% compound annual growth rate (CAGR), from $8.78M to $3.56M.